Novel injectable biodegradable glycol chitosan-based hydrogels crosslinked by Michael-type addition reaction with oligo(acryloyl carbonate)-b-poly(ethylene glycol)-b-oligo(acryloyl carbonate) copolymers

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 2, 2011, Pages 316-326

  Yu, Yuexin ^a   Deng, Chao ^a   Meng, Fenghua ^a   Shi, Qin ^b   Feijen, Jan ^a   Zhong, Zhiyuan ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

biodegradable hydrogels; chitosan; injectable; Michael addition; tissue engineering

Indexed keywords

BIODEGRADABLE HYDROGELS; CROSSLINKED; DEGREES OF SUBSTITUTION; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRICES; FIBROBLAST CELLS; GLYCOL CHITOSAN; HYBRID HYDROGELS; HYDROLYTIC DEGRADATION; IN-SITU FORMING; INJECTABLE; MICHAEL ADDITIONS; MICRO-POROUS STRUCTURE; PHYSIOLOGICAL CONDITION; POLYMER CONCENTRATIONS; RHEOLOGY MEASUREMENT; SOLUTION PH; STORAGE MODULI; WATERSOLUBLE;

ADDITION REACTIONS; ADHESION; BLOCK COPOLYMERS; CARBONATION; CELL CULTURE; CELLS; CHITOSAN; COAGULATION; CROSSLINKING; DEGRADATION; ETHYLENE; FUNCTIONAL GROUPS; GELATION; GLYCOLS; PHYSIOLOGY; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

CHITOSAN; COPOLYMER; GLYCOL CHITOSAN; GLYCYLARGINYLGLYCYLASPARTYLCYTEINE; LYSOZYME; OLIGO(ACRYLOYL CARBONATE) B POLY(ETHYLENE GLYCOL) B OLIGO(ACRYLOYL CARBONATE) COPOLYMER; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CROSS LINKING; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG SYNTHESIS; FIBROBLAST; FLOW KINETICS; GELATION; HYDROGEL; HYDROLYSIS; MICHAEL ADDITION; OSTEOBLAST;

BIOCOMPATIBLE MATERIALS; CARBONATES; CELLS, CULTURED; CHITOSAN; CROSS-LINKING REAGENTS; FIBROBLASTS; HUMANS; HYDROGELS; MATERIALS TESTING; MOLECULAR STRUCTURE; OSTEOBLASTS; POLYETHYLENE GLYCOLS; POLYMERS; TISSUE ENGINEERING;

EID: 80053202798     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33199     Document Type: Article

References (41)

1. Hoffman AS,. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002; 54: 3-12. (Pubitemid 34081178)
2. Schmidt JJ, Rowley J, Kong HJ,. Hydrogels used for cell-based drug delivery. J Biomed Mater Res Part A 2008; 87: 1113-1122.
3. Tibbitt MW, Anseth KS,. Hydrogels as extracellular matrix mimics for 3d cell culture. Biotech Bioeng 2009; 103: 655-663.
4. Yu L, Ding J,. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008; 37: 1473-1481.
5. Van Tomme SR, Storm G, Hennink WE,. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharmaceut 2008; 355: 1-18.
6. Nguyen KT, West JL,. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002; 23: 4307-4314.
7. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Langer R,. Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci USA 1999; 96: 3104-3107. (Pubitemid 29148851)
8. Crescenzi V, Cornelio L, Di Meo C, Nardecchia S, Lamanna R,. Novel hydrogels via click chemistry: Synthesis and potential biomedical applications. Biomacromolecules 2007; 8: 1844-1850. (Pubitemid 47009962)
9. van Dijk M, van Nostrum CF, Hennink WE, Rijkers DTS, Liskamp RMJ,. Synthesis and characterization of enzymatically biodegradable peg and peptide-based hydrogels prepared by click chemistry. Biomacromolecules 2010; 11: 1608-1614.
10. Jin R, Hiemstra C, Zhong ZY, Jan FJ,. Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials 2007; 28: 2791-2800. (Pubitemid 46482659)
11. Jin R, Teixeira LSM, Dijkstra PJ, Zhong ZY, van Blitterswijk CA, Karperien M, Feijen J,. Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering. Tissue Eng Part A 2010; 16: 2429-2440.
12. Lutolf MP, Hubbell JA,. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by michael-type addition. Biomacromolecules 2003; 4: 713-722. (Pubitemid 36701243)
13. Hiemstra C, van der Aa LJ, Zhong ZY, Dijkstra PJ, Feijen J,. Novel in situ forming, degradable dextran hydrogels by michael addition chemistry: Synthesis, rheology, and degradation. Macromolecules 2007; 40: 1165-1173. (Pubitemid 46383771)
14. Elbert DL, Pratt AB, Lutolf MP, Halstenberg S, Hubbell JA,. Protein delivery from materials formed by self-selective conjugate addition reactions. J Control Release 2001; 76: 11-25. (Pubitemid 32786881)
15. Metters A, Hubbell J,. Network formation and degradation behavior of hydrogels formed by Michael-type addition reactions. Biomacromolecules 2005; 6: 290-301. (Pubitemid 40277026)
16. Lutolf MP, Raeber GP, Zisch AH, Tirelli N, Hubbell JA,. Cell-responsive synthetic hydrogels. Adv Mater 2003; 15: 888-892.
17. Patterson J, Hubbell JA,. Sparc-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered peg hydrogels. Biomaterials 2011; 32: 1301-1310.
18. Patterson J, Hubbell JA,. Enhanced proteolytic degradation of molecularly engineered peg hydrogels in response to MMP-1 and MMP-2. Biomaterials 2010; 31: 7836-7845.
19. Jo YS, Rizzi SC, Ehrbar M, Weber FE, Hubbell JA, Lutolf MP,. Biomimetic peg hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides. J Biomed Mater Res Part A 2010; 93: 870-877.
20. Zustiak SP, Leach JB,. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 2010; 11: 1348-1357.
21. Pritchard CD, O'Shea TM, Siegwart DJ, Calo E, Anderson DG, Reynolds FM, Thomas JA, Slotkin JR, Woodard EJ, Langer R,. An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate. Biomaterials 2011; 32: 587-597.
22. Coviello T, Matricardi P, Marianecci C, Alhaique F,. Polysaccharide hydrogels for modified release formulations. J Control Release 2007; 119: 5-24. (Pubitemid 46561537)
23. Shu XZ, Ghosh K, Liu YC, Palumbo FS, Luo Y, Clark RA, Prestwich GD,. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res Part A 2004; 68: 365-375. (Pubitemid 38524731)
24. Ghosh K, Shu XZ, Mou R, Lombardi J, Prestwich GD, Rafailovich MH, Clark RAF,. Rheological characterization of in situ cross-linkable hyaluronan hydrogels. Biomacromolecules 2005; 6: 2857-2865. (Pubitemid 41388302)
25. Censi R, Fieten PJ, di Martino P, Hennink WE, Vermonden T,. In situ forming hydrogels by tandem thermal gelling and michael addition reaction between thermosensitive triblock copolymers and thiolated hyaluronan. Macromolecules 2010; 43: 5771-5778.
26. Hiemstra C, van der Aa LJ, Zhong ZY, Dijkstra PJ, Feijen J,. Rapidly in situ-forming degradable hydrogels from dextran thiols through michael addition. Biomacromolecules 2007; 8: 1548-1556. (Pubitemid 46865127)
27. Hiemstra C, Zhong ZY, van Steenbergen MJ, Hennink WE, Jan FJ,. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. J Control Release 2007; 122: 71-78. (Pubitemid 47284555)
28. Jukes JM, van der Aa LJ, Hiemstra C, van Veen T, Dijkstra PJ, Zhong ZY, Feijen J, van Blitterswijk CA, de Boer J,. A newly developed chemically crosslinked dextran-poly(ethylene glycol) hydrogel for cartilage tissue engineering. Tissue Eng Part A 2010; 16: 565-573.
29. Dash M, Chiellini F, Ottenbrite RM, Chiellini E,. Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 2011. Doi:10.1016/j.progpolymsci. 2011.02.001.
30. Shi CM, Zhu Y, Ran XZ, Wang M, Su YP, Cheng TM,. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 2006; 133: 185-192.
31. Kim I-Y, Seo S-J, Moon H-S, Yoo M-K, Park I-Y, Kim B-C, Cho C-S,. Chitosan and its derivatives for tissue engineering applications. Biotech Adv 2008; 26: 1-21. (Pubitemid 350138341)
32. Bhattarai N, Gunn J, Zhang M,. Chitosan-based hydrogels for !controlled, localized drug delivery. Adv Drug Deliv Rev 2010; 62: 83-99.
33. Jin R, Moreira Teixeira LS, Dijkstra PJ, Karperien M, van Blitterswijk CA, Zhong ZY, Feijen J,. Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials 2009; 30: 2544-2551.
34. Son YJ, Jang JS, Cho YW, Chung H, Park RW, Kwon IC, Kim IS, Park JY, Seo SB, Park CR, Jeong SY,. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by epr effect. J Control Release 2003; 91: 135-145. (Pubitemid 37288884)
35. Min KH, Park K, Kim Y-S, Bae SM, Lee S, Jo HG, Park R-W, Kim I-S, Jeong SY, Kim K, Kwon IK,. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008; 127: 208-218.
36. Kim J-H, Kim Y-S, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC,. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2008; 127: 41-49.
37. Xiong J, Meng F, Wang C, Cheng R, Liu Z, Zhong Z,. Folate-conjugated crosslinked biodegradable micelles for receptor-mediated delivery of paclitaxel. J Mater Chem 2011; 21: 5786-5794.
38. Chen W, Yang HC, Wang R, Cheng R, Meng FH, Wei WX, Zhong ZY,. Versatile synthesis of functional biodegradable polymers by combining ring-opening polymerization and postpolymerization modification via Michael-type addition reaction. Macromolecules 2010; 43: 201-207.
39. Lutolf MP, Tirelli N, Cerritelli S, Cavalli L, Hubbell JA,. Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. Bioconjugate Chem 2001; 12: 1051-1056. (Pubitemid 33136878)
40. Hern DL, Hubbell JA,. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998; 39: 266-276. (Pubitemid 28060360)
41. Zhang Z, Lai Y, Yu L, Ding J,. Effects of immobilizing sites of RGD peptides in amphiphilic block copolymers on efficacy of cell adhesion. Biomaterials 2010; 31: 7873-7882.